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Introduction
Environmental persistence of multidrug-resistant (MDR)
organisms in hospital environment is arduous to reduce or
eliminate. Efficacy’s inconsistency characterizing manual dis-
infection that generates high levels of residual surface con-
tamination compounds adversities in achieving reduction.
Objectives
Study evaluated a novel no-touch disinfection technology
named HyperDRYMist®, which decontaminates hard sur-
faces by delivering aerosolized enhanced Hydrogen Perox-
ide, as an addition to manual disinfection (terminal
cleaning).
Methods
Hard surfaces of 20 hospital rooms occupied by patients
affected by classic MDR bacteria prospectively sampled for
contamination in 10 standardized high-touch points fol-
lowing patient’s discharge. Measurements taken after man-
ual disinfection with active chlorine (2000 ppm), before
micro-nebulization via HDM® and after it. Eventual resi-
dual bacterial contamination excluded by enriched broth
culture.
Results
For 8 months, prospectively identified and included 20
cases of “classic” MDR patients (see list below). After term-
inal cleaning, mean residual bacterial contamination was
59,27±78,89 (mean± SD) cfu/ml, with values reaching up to
400 cfu/ml, then reduced to 2,48±12,07 (p < 0.0001) after
HDM®. Purposely searched for environmental presence of
MDR after conventional cleaning. In 14/20 rooms MDRs
bacteria still detected, in particular found MRSA in 4 of 4
rooms, Acinetobacter baumanii in 2/2, MDR Pseudomonas
in 2/2, KPC in 2/4, VRE in 0/2, E.coli ESBL 2/2, K. pneu-
monia ESBL 0/2, Stenotrophomonas maltophilia 2/2. After
HDM® in none of the rooms MDR bacteria detected.
Conclusion
Study confirms how significant levels of environmental
contamination persist when solely manual disinfection is
adopted to eradicate MDR bacteria from surfaces. In
spite of quality certified protocols, overall inconsistency
of results observed with degrees of efficacy clearly
operator’s dependent. HDM® brought consistency of
results in drastically reducing pathogens’ presence.
Persistence of MDRs in rooms sampled suggests sur-
faces may play pivotal role for HAI transmission, hence
the advantages of disinfection technologies like HDM®
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